104P - Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors
| Autor: | Melero, I., Segal, N.H., Saro, J., Ros, W., Martinez-Garcia, M., Argiles, G., Moreno, V., Ponce, S., Marabelle, A., Cleary, J.M., Hurwitz, H.I., Eder, J.P., Jamois, C., Andersson, E., Bouseida, S., Sandoval, F., Bacac, M., Nayak, T., Karanikas, V., Calvo, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v28-v28 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|